Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TMC Life Sciences BhdXKLS:0101 60 5-Year Yield-on-Cost % is 1.10 as of Jul. 20, 2026, which is 8% above its 10-year median of 1.02. GuruFocus rates XKLS:0101 with a GF Score™ of 60/100 and a GF Value™ of RM0.62 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 279 Healthcare Providers & Services companies, TMC Life Sciences Bhd ranks worse than 77.06% on this metric.
TMC Life Sciences Bhd's yield on cost for the quarter that ended in Mar. 2026 was 1.10.
The historical rank and industry rank for TMC Life Sciences Bhd's 5-Year Yield-on-Cost % or its related term are showing as below:
XKLS:0101'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.27 Med: 1.02 Max: 3.49
Current: 1.1
During the past 13 years, TMC Life Sciences Bhd's highest Yield on Cost was 3.49. The lowest was 0.27. And the median was 1.02.
XKLS:0101's 5-Year Yield-on-Cost % is ranked worse than 77.06% of 279
companies
in the Healthcare Providers & Services industry
Industry Median: 2.93
vs XKLS:0101: 1.10
TMC Life Sciences Bhd (XKLS:0101) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
TMC Life Sciences Bhd 5-Year Yield-on-Cost % Related Terms
XKLS:0101 vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, TMC Life Sciences Bhd's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TMC Life Sciences Bhd 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TMC Life Sciences Bhd's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where TMC Life Sciences Bhd's 5-Year Yield-on-Cost % falls into.
TMC Life Sciences Bhd 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
TMC Life Sciences Bhd (XKLS:0101) has a 5-Year Yield-on-Cost % of 1.10 as of Jul. 20, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on TMC Life Sciences Bhd and its competitors. This is near median its historical median of 1.02. Over the past decade, TMC Life Sciences Bhd's 5-Year Yield-on-Cost % has ranged from 0.27 to 3.49. According to the industry distribution chart, TMC Life Sciences Bhd ranks #215 out of 279 companies in the Healthcare Providers & Services industry, placing it in the top 77.1%.
Is TMC Life Sciences Bhd's 5-Year Yield-on-Cost % too high?
TMC Life Sciences Bhd's current 5-Year Yield-on-Cost % of 1.10 is near median its 10-year median of 1.02. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 3.49. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.93. TMC Life Sciences Bhd's value of 1.10 is 62.5% below this industry median. Based on the distribution chart, TMC Life Sciences Bhd ranks #215 out of 279 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, TMC Life Sciences Bhd has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TMC Life Sciences Bhd's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, TMC Life Sciences Bhd ranks #215 out of 279 companies for 5-Year Yield-on-Cost %. This places TMC Life Sciences Bhd in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. TMC Life Sciences Bhd's value of 1.10 is 62.5% below this benchmark. Historically, TMC Life Sciences Bhd's own 5-Year Yield-on-Cost % has ranged from 0.27 to 3.49 over the past decade. While the company's 10-year median is 1.02 vs. the industry median of 2.93, TMC Life Sciences Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 279 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TMC Life Sciences Bhd's current 5-Year Yield-on-Cost % of 1.10 is 62.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on TMC Life Sciences Bhd and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TMC Life Sciences Bhd's current 5-Year Yield-on-Cost % is 1.10, which is near median its own 10-year median of 1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TMC Life Sciences Bhd stock overvalued right now?
Based on GuruFocus' analysis, TMC Life Sciences Bhd (XKLS:0101) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.62, compared to a current price of RM0.47 — trading 24.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.10, which is near median its 10-year median of 1.02 and 62.5% below the Healthcare Providers & Services industry median of 2.93. TMC Life Sciences Bhd's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For TMC Life Sciences Bhd (XKLS:0101), the current 5-Year Yield-on-Cost % is 1.10 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TMC Life Sciences Bhd (XKLS:0101) Overvalued in 2026?
Based on GuruFocus' analysis, TMC Life Sciences Bhd stock appears to be undervalued.
The current stock price of RM0.47 is trading 24.2% below its estimated GF Value™ of RM0.62.
GuruFocus considers TMC Life Sciences Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0101:
5-Year Yield-on-Cost %: 1.10 (near median its 10-year median of 1.02)
GF Value™: RM0.62 vs. price of RM0.47 (24.2% below fair value)
Industry Position: 62.5% below the Healthcare Providers & Services median (#215 of 279)
No single metric tells the full story. See the XKLS:0101 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TMC Life Sciences Bhd is an investment holding company operating a multi-disciplinary tertiary care center and fertility center in Malaysia. It operates Tropicana Medical Centre, Kota Damansara (TMCKD), a medical center located in Petaling Jaya. Its TMCKD provides healthcare services in various medical/surgical specialties and subspecialties, including anesthesiology, cancer, cardiology, colorectal, dermatology, ENT, fertility, gastroenterology, as well as offers internal medicines and respiratory medicines. Its fertility center provides a range of fertility treatments for couples. The company also operates a women's clinic; provides fertility consultancy, laboratory, and embryology services; and offers pharmacy services and products.
60GF Score
Get the complete analysis for XKLS:0101
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0101 has been successfully added to your 
